
    
      Monitoring :

      For index cases group, all the data will be monitored. For the relatives group, only the
      informed consent will be monitored

      Statistical analysis :

        -  Evaluate the additional elucidation rate of unexpected sudden death

        -  Evaluate causes obtained by Next Generation Sequencing (NGS) ( in comparison with
           conventional autopsy (macroscopic and / or microscopic)

        -  Descriptive study of the causes of sudden unexpected death, identified hereditary
           cardiac causes percentages compared via various diagnostic approaches

        -  Cost-effectiveness analysis

      Data Management :

      A database is created for the AGEMOS study with control of the discrepancies. All the index
      cases' data entered in the data base will be double checked
    
  